BR0213907A - Derivados de heteroarila como ligandos superiores para receptor de nociceptina orl-1 - Google Patents

Derivados de heteroarila como ligandos superiores para receptor de nociceptina orl-1

Info

Publication number
BR0213907A
BR0213907A BR0213907-3A BR0213907A BR0213907A BR 0213907 A BR0213907 A BR 0213907A BR 0213907 A BR0213907 A BR 0213907A BR 0213907 A BR0213907 A BR 0213907A
Authority
BR
Brazil
Prior art keywords
orl
nociceptin receptor
heteroaryl derivatives
ligands
superior
Prior art date
Application number
BR0213907-3A
Other languages
English (en)
Inventor
Deen Tulshian
Gunny D Ho
Fay W Ng
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR0213907A publication Critical patent/BR0213907A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

"DERIVADOS DE HETEROARILA COMO LIGANDOS SUPERIORES PARA RECEPTOR DE NOCICEPTINA ORL-1". A presente invenção refere-se a compostos de fórmula (I), em que R é heteroarila opcionalmente substituída ou (a); R^ 1^ é H ou C~ 1~-C~ 6~ alquila; e R^ 2^ e R^ 3^ são -CH~ 3~, -OCH~ 3~ ou halo; ou um sal ou solvato farmaceuticamente aceitável dos mesmos, as composições farmacêuticas assim obtidas, e o uso dos referidos compostos no tratamento da dor, ansiedade, tosse, asma, depressão e uso excessivo de álcool.
BR0213907-3A 2001-11-07 2002-11-06 Derivados de heteroarila como ligandos superiores para receptor de nociceptina orl-1 BR0213907A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33328401P 2001-11-07 2001-11-07
PCT/US2002/035539 WO2003039469A2 (en) 2001-11-07 2002-11-06 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1

Publications (1)

Publication Number Publication Date
BR0213907A true BR0213907A (pt) 2004-09-28

Family

ID=23302135

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213907-3A BR0213907A (pt) 2001-11-07 2002-11-06 Derivados de heteroarila como ligandos superiores para receptor de nociceptina orl-1

Country Status (27)

Country Link
US (1) US6727254B2 (pt)
EP (1) EP1442036B1 (pt)
JP (2) JP4246066B2 (pt)
KR (1) KR100596261B1 (pt)
CN (1) CN1252068C (pt)
AR (1) AR037211A1 (pt)
AT (1) ATE315566T1 (pt)
BR (1) BR0213907A (pt)
CA (1) CA2465871C (pt)
CY (1) CY1105208T1 (pt)
DE (1) DE60208724T2 (pt)
DK (1) DK1442036T3 (pt)
EC (1) ECSP045096A (pt)
ES (1) ES2256590T3 (pt)
HK (1) HK1063019A1 (pt)
HU (1) HUP0402329A2 (pt)
IL (2) IL161120A0 (pt)
MX (1) MXPA04004276A (pt)
MY (1) MY126268A (pt)
NO (1) NO329026B1 (pt)
NZ (1) NZ532088A (pt)
PE (1) PE20030719A1 (pt)
PL (1) PL370269A1 (pt)
RU (1) RU2327698C2 (pt)
TW (1) TWI317360B (pt)
WO (1) WO2003039469A2 (pt)
ZA (1) ZA200403404B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
US20040067950A1 (en) * 1998-07-27 2004-04-08 Schering-Plough Corporation High affinity ligands for nociceptin receptor ORL-1
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
ATE443699T1 (de) * 2002-12-06 2009-10-15 Purdue Research Foundation Pyridine zur behandlung von verletztemsäugetiernervengewebe
WO2005089761A1 (en) * 2004-03-17 2005-09-29 Pfizer Limited Combination for treating inflammatory diseases
EP1791838A2 (en) * 2004-09-15 2007-06-06 Schering-Plough Ltd. Process for preparing substituted 8-azabicyclo[3.2.1] octan-3-ols
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
PE20071159A1 (es) * 2005-10-31 2007-11-30 Schering Corp Derivados de tropano 3-monosustituido como ligandos de receptores de nociceptina
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
WO2010010458A1 (en) * 2008-07-21 2010-01-28 Purdue Pharma L.P. Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
GB201004311D0 (en) 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
GB201115853D0 (en) 2011-09-14 2011-10-26 Proximagen Ltd New enzyme inhibitor compounds
US9724340B2 (en) * 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352707A (en) 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
TW590268U (en) * 2000-08-08 2004-06-01 Wistron Corp Heat dissipating device

Also Published As

Publication number Publication date
RU2004117542A (ru) 2006-01-10
PL370269A1 (en) 2005-05-16
TW200301765A (en) 2003-07-16
CA2465871A1 (en) 2003-05-15
CN1252068C (zh) 2006-04-19
DE60208724D1 (de) 2006-04-06
ATE315566T1 (de) 2006-02-15
NZ532088A (en) 2006-05-26
WO2003039469A3 (en) 2003-10-16
HK1063019A1 (en) 2004-12-10
ES2256590T3 (es) 2006-07-16
EP1442036A2 (en) 2004-08-04
US20030119847A1 (en) 2003-06-26
JP2005508367A (ja) 2005-03-31
MXPA04004276A (es) 2004-08-11
KR20050043725A (ko) 2005-05-11
CY1105208T1 (el) 2010-03-03
CN1582288A (zh) 2005-02-16
DE60208724T2 (de) 2006-11-02
JP4246066B2 (ja) 2009-04-02
KR100596261B1 (ko) 2006-06-30
TWI317360B (en) 2009-11-21
NO20042294L (no) 2004-07-15
HUP0402329A2 (hu) 2005-02-28
CA2465871C (en) 2009-01-20
IL161120A (en) 2010-11-30
MY126268A (en) 2006-09-29
AR037211A1 (es) 2004-10-27
DK1442036T3 (da) 2006-05-15
ECSP045096A (es) 2004-06-28
IL161120A0 (en) 2004-08-31
EP1442036B1 (en) 2006-01-11
RU2327698C2 (ru) 2008-06-27
US6727254B2 (en) 2004-04-27
NO329026B1 (no) 2010-08-02
WO2003039469A2 (en) 2003-05-15
JP2009035556A (ja) 2009-02-19
ZA200403404B (en) 2005-08-15
PE20030719A1 (es) 2003-08-28

Similar Documents

Publication Publication Date Title
BR0213907A (pt) Derivados de heteroarila como ligandos superiores para receptor de nociceptina orl-1
BR0111015A (pt) Antagonistas de receptor a2a de adenosina
BR0211284A (pt) Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, a respectiva preparação e a respectiva aplicação em terapêutica
BRPI0407976A (pt) tetrahidroisoquinolinas substituìdas em 2,5 e 2,6 para uso como moduladores de 5-ht6
BRPI0512985A (pt) derivados de 3-carbamoil-2-piridona
BRPI0113146B8 (pt) &#34;derivados de prolina e composição farmacêutica que os compreende&#34;.
BR0213877A (pt) Compostos orgânicos
BR0210538A (pt) Derivados de 5-halotriptamina usados como ligantes dos receptores de serotonina 5-ht6 e/ou 5-ht7
BRPI0513672A (pt) processo aperfeiçoado para a preparação de 2h-1-benzopiran-2metanol, (alfa). (alfa)&#39; [iminobis (metileno)] bis [6-fluoro-3, 4-dihidro, [2r* [r* [r* (s*)]]]], composição farmacêutica, forma t1 amorfa, e processo para a preparação da forma t1 de hidrocloreto de nebivolol
BRPI0414514A (pt) uso de um composto, composto, e, composições farmacêuticas
BR0317645A (pt) Composto ou um sal deste, composição farmacêutica, uso de um composto, e, método de tratamento e/ou profilaxia de uma doença inflamatória e/ou alérgica ou deterioração cognitiva em um mamìfero
BR0211262A (pt) Tienopirimidinodionas e seu uso na modulação de doenças autoimunes
BR0111377A (pt) Derivados de tiofeno úteis como agentes anticancerìgenos
BRPI0110955B8 (pt) derivados de tropano composição farmacêutica, uso dos mesmos na fabricação de um medicamento bem como processo para a preparação dos mesmos.
BR0010520A (pt) Novos compostos farmaceuticamente ativos
HUP0302526A2 (hu) Makrolid vegyületek, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
BR0112856A (pt) Método para o tratamento dos distúrbios, composto ou um sal ou solvato deste, processo para a preparação dos mesmos, composição farmacêutico, método de tratamento e/ou profilaxia de um ou mais dos distúrbios, uso de um composto, e, método para o tratamento de diabetes, grande depressão, depressão manìaca, ansiedade, esquizofrenia e distúrbios do sono, em mamìferos humanos e não humanos
BR0210028A (pt) Agentes antibacterianos
BRPI0407253A (pt) Heterociclil-3-sulfonilindazóis como ligandos 5-hidroxitriptamina-6 processo de preparação dos mesmos, seus usos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os referidos compostos
BRPI0411285A (pt) composto, processo para preparar um composto formulação farmacêutica, uso de um composto, e, método de prevenção ou tratamento de distúrbios
UY27593A1 (es) Nuevos compuestos
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
BR0316950A (pt) Derivados de indazol como antagonistas de crf
BR0310032A (pt) Derivados de benzoxazina como moduladores de 5-ht6 e usos dos mesmos
BRPI0507636A (pt) compostos, derivados terapêuticos de amida, composição farmacêutica, uso dos mesmos e combinação

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: C07D 451/06, A61K 31/46, A61P 43/00

Ipc: C07D 451/06 (2011.01), A61K 31/46 (2011.01), A61P

B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]